(Fighting New Coronary Pneumonia) Malaysian companies and China Kexing signed a new crown vaccine procurement agreement
China News Agency, Kuala Lumpur, January 12 (Reporter Chen Yue) Pharmania, a Malaysian company, signed a new crown vaccine procurement agreement with China Kexing Zhongwei Biotechnology Co., Ltd. on the 12th.
On January 12, Malaysian company Pharmania and China Kexing Zhongwei Biotechnology Co., Ltd. signed an online purchase agreement for 14 million doses of COVID-19 vaccine.
The picture shows the person in charge of Pharmania in Kuala Lumpur under the witness of Malaysia's Minister of Science, Technology and Innovation Carey, Minister of Defense Ismail, Minister of Health Azam (from left to right in the back row) and other witnesses.
Photo by China News Agency reporter Chen Yue
According to the online agreement signed by the two parties on the same day, Pharmania will purchase 14 million doses of the new crown vaccine developed by Kexing Biotechnology.
According to Malaysian sources, Kexing Bio will provide semi-finished vaccine products and package them in Malaysia by Pharmania.
Malaysian Defense Minister Ismail, Science, Technology and Innovation Minister Carey, and Health Minister Azam attended the signing ceremony.
Carey said that as the Malaysian Chinese companies reach an agreement, the Malaysian government will also sign a purchase agreement for this batch of vaccines in the near future.
The person in charge of Pharmania expects that this batch of vaccines is expected to be distributed to local hospitals in Malaysia before the end of March this year.
(Finish)